Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Finnegan Frederick, Directeur Commercial. Insider active across 1 company, notably SAB Biotherapeutics, Inc.. Cumulatively, 1 disclosures have been logged. Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Frederick Finnegan serves as Chief Business Officer at SAB Biotherapeutics, Inc. In this role, he is responsible for business strategy and development. His expertise enables him to identify new market opportunities and strengthen relationships with strategic partners. He plays a key role in the growth and expansion of the company.